Configurable cardioversion and defibrillation therapies in the presence of coexisting atrial and ventricular arrhythmia

• US 7,313,436 B2
• Filed: 04/30/2003
• Issued: 12/25/2007
• Est. Priority Date: 04/30/2003
• Status: Expired due to Fees

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Hess, Michael F.
• Primary Examiner(s): Sykes; Angela D.
• Assistant Examiner(s): KAHELIN, MICHAEL WILLIAM
• Application Number:
  US10/426,495
• Publication Number:
  US 20040220623A1
• Time in Patent Office: 1,700 Days
• Field of Search: 607/4, 607/5, 607/9, 607/14
• US Class Current: 607/5
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/3918 characterised by shock pathway, e.g. by electrode configuration
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

An implantable cardioverter defibrillator system and method are provided having configurable shock therapies selected based on an evaluation of the atrial rhythm status following a ventricular tachycardia or fibrillation detection. A dual chamber shock configuration is selected if the ventricular arrhythmia is co-existing with an atrial arrhythmia of recent onset. A ventricular only shock configuration is selected if the ventricular arrhythmia is co-existing with a sustained atrial arrhythmia.

Claims

1. An implantable medical device, comprising:

a plurality of electrodes sensing cardiac signals within a plurality of chambers of a heart; and

control circuitry determining cardiac events in response to the sensed cardiac signals, and delivering a therapy via selected ones of the plurality of electrodes for a first determined cardiac event in response to presence of a second cardiac event, wherein the control circuitry determines, in response to the sensed cardiac signals corresponding to the second cardiac event, whether the second cardiac event is either one of a sustained cardiac event and a recent-onset cardiac event, and selects one of a first shock therapy comprising a defibrillation configuration delivered for simultaneously treating the first cardiac event and the second cardiac event in response to the second cardiac event being a recent-onset cardiac event and a second shock therapy comprising a defibrillation configuration delivered for treating only the first cardiac event and not the second cardiac event in response to the second cardiac event being a sustained cardiac event.

2. The device of claim 1, wherein the first cardiac event corresponds to one of a ventricular tachycardia and a ventricular fibrillation, and the second event corresponds to one of atrial tachycardia and atrial fibrillation.

3. The device of claim 1, wherein the control circuitry determines a time duration of the second cardiac event, and determines that the second cardiac event is a sustained cardiac event in response to the determined time duration being greater than a predetermined time period.

4. The device of claim 3, wherein the predetermined time period is approximately 24 hours.

5. The device of claim 1, wherein the first shock therapy configuration is delivered to treat more than one chamber of the heart and the second therapy is delivered to treat only a single chamber of the heart.

6. The device of claim 5, wherein the more than one chamber corresponds to a ventricle and an atrium of the heart and the single chamber corresponds to a ventricle of the heart.

7. The device of claim 1, wherein the control circuit selects parameters associated with the first shock therapy configuration, including parameters associated with simultaneously terminating both the first cardiac event and the second cardiac event, in response to the determined cardiac events and delivers a single shock according to the parameters associated with simultaneously terminating both the first cardiac event and the second cardiac event.

8. The device of claim 7, wherein the parameters include one or more of a shock vector, a shock energy, a tilt, a waveform, and a waveshape.

9. The device of claim 1, wherein the control circuitry monitors success of the second shock therapy configuration in terminating the first cardiac event, determines whether termination of the first cardiac event is delayed as a result of delivery of the second shock therapy configuration, and selects a third shock therapy configuration in response to the termination of the first cardiac event being delayed.

10. The device of claim 1, wherein the control circuitry determines whether the first cardiac event has terminated, adjusts the second shock therapy configuration and delivers the single shock according to the adjusted second shock therapy configuration in response to the first cardiac event not being terminated, monitors success of the second shock therapy configuration and the adjusted second shock therapy configuration in terminating the first cardiac event to determine whether the second shock therapy configuration and the adjusted second shock therapy configuration are acceptable, and adjusts the second shock therapy configuration to correspond to the adjusted second shock therapy configuration in response to the second shock therapy configuration being unacceptable and the adjusted second shock therapy configuration being acceptable.

11. A method of controlling delivery of therapy in an implantable medical device, comprising:

sensing cardiac signals;

determining whether sensed cardiac signals correspond to a first cardiac event and a second cardiac event,

determining, in response to the sensed cardiac signals corresponding to the first cardiac event and the second cardiac event, whether the second cardiac event is either one of a sustained cardiac event and a recent-onset cardiac event, and

selecting one of a first shock therapy comprising a first defibrillation configuration corresponding to simultaneously treating the first cardiac event and the second cardiac event in response to the second cardiac event being a recent-onset cardiac event and a second shock therapy comprising a second defibrillation configuration corresponding to treating only the first cardiac event and not the second cardiac event in response to the second cardiac event being a sustained cardiac event.

12. The method of claim 11, wherein the first cardiac event corresponds to one of a ventricular tachycardia and a ventricular fibrillation, and the second cardiac event corresponds to one of atrial tachycardia and atrial fibrillation.

13. The method of claim 11, wherein determining whether the second cardiac event is either one of a sustained cardiac event and a recent-onset cardiac event includes determining a time duration of the second cardiac event and determining the second cardiac event is a sustained cardiac event in response to the determined time duration being greater than a predetermined time period.

14. The method of claim 11, wherein the predetermined time period is approximately 24 hours.

15. The method of claim 11, wherein the first shock therapy configuration is delivered to treat more than one chamber of the heart and the second shock therapy configuration is delivered to treat only a single chamber of the heart.

16. The method of claim 15, wherein the more than one chamber corresponds to a ventricle and an atrium of the heart and the single chamber corresponds to a ventricle of the heart.

17. The method of claim 11 wherein selecting one of the first shock therapy configuration and the second shock therapy configuration includes selecting therapy delivery parameters and wherein selecting the first shock therapy configuration includes selecting therapy delivery parameters associated with delivering a single shock for simultaneously terminating both the first cardiac event and the second cardiac event.

18. The method of claim 17, wherein the therapy delivery parameters include one or more of a shock vector, a shock energy, a tilt, a waveform, and a waveshape.

19. The method of claim 11, further including monitoring success of the second shock therapy configuration in terminating the first cardiac event, determining whether termination of the first cardiac event is delayed as a result of delivery of the second shock therapy configuration, and delivering a third shock therapy configuration in response to the termination of the first cardiac event being delayed.

20. The method of claim 11, further including determining whether the first cardiac event has terminated, adjusting the second shock therapy configuration and delivering the adjusted second shock therapy configuration in response to the first cardiac event not being terminated, monitoring the success of the second shock therapy configuration and the adjusted second shock therapy configuration in terminating the first cardiac event to determine whether the second shock therapy configuration and the adjusted second shock therapy configuration are acceptable, and adjusting the second shock therapy configuration to correspond to the adjusted second shock therapy configuration in response to the second shock therapy configuration being unacceptable and the adjusted second shock therapy configuration being acceptable.

21. A computer readable medium having computer-executable instructions for performing a method comprising:

sensing cardiac signals;

determining whether sensed cardiac signals correspond to a first cardiac event and a second cardiac event,

determining, in response to the sensed cardiac signals corresponding to the first cardiac event and the second cardiac event, whether the second cardiac event is either one of a sustained cardiac event and a recent-onset cardiac event, and

selecting one of a first shock therapy comprising a defibrillation configuration corresponding to simultaneously treating the first cardiac event and the second cardiac event in response to the second cardiac event being a recent-onset cardiac event and a second shock therapy comprising a defibrillation configuration corresponding to treating only the first cardiac event and not the second cardiac event in response to the second cardiac event being a sustained cardiac event.

22. An implantable medical device, comprising:

a plurality of electrodes sensing cardiac signals within a plurality of chambers of a heart; and

control circuitry determining cardiac events in response to the sensed cardiac signals, and delivering a shock therapy via selected ones of the plurality of electrodes for a first determined cardiac event in response to presence of a second cardiac event;

wherein the first cardiac event corresponds to ventricular fibrillation and the second cardiac event corresponds to one of atrial tachycardia and atrial fibrillation;

wherein the control circuitry determines, in response to the sensed cardiac signals corresponding to the second cardiac event, whether the second cardiac event is either one of a sustained cardiac event and a recent-onset cardiac event, and selects one of a first shock therapy comprising a defibrillation configuration corresponding to simultaneously treating the first cardiac event and the second cardiac event in response to the second cardiac event being a recent-onset cardiac event and a second shock therapy comprising a defibrillation configuration corresponding to treating only the first cardiac event and not the second cardiac event in response to the second cardiac event being a sustained cardiac event;

wherein the first shock therapy configuration comprises a single shock therapy configured to simultaneously terminate the first cardiac event and the second cardiac event and the second shock therapy configuration comprises a single shock therapy configured to terminate only the first cardiac event without terminating the second cardiac event.